Bladder Cancer Clinical Trials in San Antonio, Texas
5 studies are recruiting for bladder cancer in San Antonio, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
The purpose of this study is to find out whether the study drug, LY4052031, is safe, tolerable and effective in participants with advanced, or metastatic solid tumors including urothelial cancer. The study is conducted in two parts - phase Ia (dose-escalation, dose-optimization) and phase Ib (dose-…
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- South Texas Accelerated Research Therapeutics (START), San Antonio, Texas
- Locations
- 39 in total
- Run by
- Eli Lilly and Company
-
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
The purpose of the study is to explore the safety and effects of the study drug (PF-08046876) in people diagnosed with advanced cancer of the bladder, lung, head and neck, esophagus, or pancreas. PF-08046876 is an investigational anticancer therapy called an 'antibody drug conjugate' or 'ADC'. ADCs…
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- NEXT Oncology, San Antonio, Texas
- Locations
- 31 in total
- Run by
- Pfizer
-
IDOV-Immune for Advanced Solid Tumors
This is a Phase I clinical trial evaluating an investigational treatment called IDOV-Immune, a type of oncolytic virus therapy, for adults with advanced solid tumors that have not responded to standard treatments. Oncolytic viruses are designed to infect and destroy cancer cells and have the potent…
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- South Texas Accelerated Research Therapeutics, San Antonio, Texas
- Locations
- 5 in total
- Run by
- ViroMissile, Inc.
-
Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer
This is a prospective, multicenter observational study designed to collect urine and tumor biospecimens and associated clinical data from patients undergoing evaluation, treatment, or surveillance for urothelial carcinoma.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Urology San Antonio, San Antonio, Texas
- Locations
- 23 in total
- Run by
- Convergent Genomics, Inc.
-
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
The goal of this clinical trial is to learn if an investigational drug CP-383 works to treat advanced cancer. It will also learn about the safety of CP-383. The main questions if aims to answer are: * Does CP-383 slow or stop the growth of cancer in patients with advanced cancer * What medical prob…
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- START San Antonio, San Antonio, Texas
- Locations
- 13 in total
- Run by
- Tasca Therapeutics
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.